KATEY ROBINFIELD: Open Payments
NPI 1386261451 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$851 in 35 payments from 14 companies in 2025. Trend: 2023 $988 · 2024 $1,422 · 2025 $851
Food & beverage: $851
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $189 |
| GlaxoSmithKline, LLC. | 5 | $92 |
| United Therapeutics Corporation | 4 | $92 |
| Verona Pharma, Inc. | 4 | $88 |
| GENZYME CORPORATION | 1 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $78 |
| Regeneron Healthcare Solutions, Inc. | 4 | $77 |
| Mallinckrodt Hospital Products Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Viatris Specialty LLC | 1 | $25 |
Products named: DUPIXENT, FASENRA, Tyvaso, Ohtuvayre, OFEV, NUCALA, ACTHAR, AIRSUPRA.
Industry payments across NC — which companies pay providers there.
